ADMA BIOLOGICS, INC. 4
4 · ADMA BIOLOGICS, INC. · Filed Feb 1, 2016
Insider Transaction Report
Form 4
Mond James
CSO/CMO
Transactions
- Award
Options to purchase
2016-01-28+6,750→ 6,750 totalExercise: $5.96Exp: 2026-01-28→ Common Stock (6,750 underlying)
Footnotes (2)
- [F1]The exercise price reflects the per share fair market value of the Company's common stock, as determined by the closing price of the Company's common stock on the NASDAQ Stock Market on January 28, 2016, the date that the option grant was approved by the Company's board of directors.
- [F2]These options vest over four years with 25% vesting on the one year anniversary of the date of grant and the remaining 75% vesting monthly in equal installments over the next three years.